{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:48:09Z","timestamp":1793195289643,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22037007; 21725801"],"award-info":[{"award-number":["22037007; 21725801"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22107109"],"award-info":[{"award-number":["22107109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341002, 32293192 and 82030083"],"award-info":[{"award-number":["82341002, 32293192 and 82030083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China is launched by the Ministry of Science and Technology of the People&apos;s Republic of China."},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["2023297"],"award-info":[{"award-number":["2023297"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chemo-activation of mitochondrial ClpP exhibits promising anticancer properties. However, we are currently unaware of any studies using selective and potent ClpP activators in lung squamous cell carcinoma. In this work, we report on such an activator, ZK53, which exhibits therapeutic effects on lung squamous cell carcinoma in vivo. The crystal structure of ZK53\/ClpP complex reveals a \u03c0-\u03c0 stacking effect that is essential for ligand binding selectively to the mitochondrial ClpP. ZK53 features on a simple scaffold, which is distinct from the activators with rigid scaffolds, such as acyldepsipeptides and imipridones. ZK53 treatment causes a decrease of the electron transport chain in a ClpP-dependent manner, which results in declined oxidative phosphorylation and ATP production in lung tumor cells. Mechanistically, ZK53 inhibits the adenoviral early region 2 binding factor targets and activates the ataxia-telangiectasia mutated-mediated DNA damage response, eventually triggering cell cycle arrest. Lastly, ZK53 exhibits therapeutic effects on lung squamous cell carcinoma cells in xenograft and autochthonous mouse models.<\/jats:p>","DOI":"10.1038\/s41467-023-42784-4","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T18:02:28Z","timestamp":1699034548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3525-8779","authenticated-orcid":false,"given":"Lin-Lin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3287-4629","authenticated-orcid":false,"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0619-9319","authenticated-orcid":false,"given":"Yun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8914-2248","authenticated-orcid":false,"given":"Chuan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-7204","authenticated-orcid":false,"given":"Yihui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4475-2381","authenticated-orcid":false,"given":"Pengyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2015-9508","authenticated-orcid":false,"given":"Meixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-4737","authenticated-orcid":false,"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8140-9259","authenticated-orcid":false,"given":"Kan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8438-8852","authenticated-orcid":false,"given":"Jianhua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-6390","authenticated-orcid":false,"given":"Hongbin","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5778-4422","authenticated-orcid":false,"given":"Cai-Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"42784_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J Nunnari","year":"2012","unstructured":"Nunnari, J. & Suomalainen, A. Mitochondria: in sickness and in health. Cell 148, 1145\u20131159 (2012).","journal-title":"Cell"},{"key":"42784_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03062-z","volume":"11","author":"K Nouri","year":"2020","unstructured":"Nouri, K., Feng, Y. & Schimmer, A. D. Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy. Cell Death Dis. 11, 841 (2020).","journal-title":"Cell Death Dis."},{"key":"42784_CR3","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.cbpa.2021.07.003","volume":"66","author":"MF Mabanglo","year":"2021","unstructured":"Mabanglo, M. F., Bhandari, V. & Houry, W. A. Substrates and interactors of the ClpP protease in the mitochondria. Curr. Opin. Chem. Biol. 66, 102078 (2021).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"42784_CR4","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton, T. M., McKenna, W. G., Kunz-Schughart, L. A. & Higgins, G. S. Oxidative phosphorylation as an emerging target in cancer therapy. Clin. Cancer Res. 24, 2482\u20132490 (2018).","journal-title":"Clin. Cancer Res."},{"key":"42784_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1021\/acschembio.8b00124","volume":"13","author":"V Bhandari","year":"2018","unstructured":"Bhandari, V. et al. The role of ClpP protease in bacterial pathogenesis and human diseases. ACS Chem. Biol. 13, 1413\u20131425 (2018).","journal-title":"ACS Chem. Biol."},{"key":"42784_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.chembiol.2018.05.014","volume":"25","author":"KS Wong","year":"2018","unstructured":"Wong, K. S. et al. Acyldepsipeptide analogs dysregulate human mitochondrial ClpP protease activity and cause apoptotic cell death. Cell Chem. Biol. 25, 1017\u20131030 e1019 (2018).","journal-title":"Cell Chem. Biol."},{"key":"42784_CR7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1021\/acschembio.9b00222","volume":"14","author":"PR Graves","year":"2019","unstructured":"Graves, P. R. et al. Mitochondrial protease ClpP is a target for the anticancer compounds ONC201 and related analogues. ACS Chem. Biol. 14, 1020\u20131029 (2019).","journal-title":"ACS Chem. Biol."},{"key":"42784_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2019.03.014","volume":"35","author":"J Ishizawa","year":"2019","unstructured":"Ishizawa, J. et al. Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality. Cancer Cell 35, 721\u2013737.e729 (2019).","journal-title":"Cancer Cell"},{"key":"42784_CR9","doi-asserted-by":"publisher","first-page":"e00993","DOI":"10.1002\/prp2.993","volume":"10","author":"EMJ Fennell","year":"2022","unstructured":"Fennell, E. M. J. et al. Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpP. Pharmacol. Res. Perspect. 10, e00993 (2022).","journal-title":"Pharmacol. Res. Perspect."},{"key":"42784_CR10","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.1021\/acs.jmedchem.1c02071","volume":"65","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Discovery of a novel series of imipridone compounds as Homo sapiens caseinolytic protease P agonists with potent antitumor activities in vitro and in vivo. J. Med. Chem. 65, 7629\u20137655 (2022).","journal-title":"J. Med. Chem."},{"key":"42784_CR11","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.chembiol.2022.07.002","volume":"29","author":"P Wang","year":"2022","unstructured":"Wang, P. et al. Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma. Cell Chem. Biol. 29, 1396\u20131408.e1398 (2022).","journal-title":"Cell Chem. Biol."},{"key":"42784_CR12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.drudis.2021.01.007","volume":"26","author":"B Luo","year":"2021","unstructured":"Luo, B., Ma, Y., Zhou, Y., Zhang, N. & Luo, Y. Human ClpP protease, a promising therapy target for diseases of mitochondrial dysfunction. Drug Discov. Today 26, 968\u2013981 (2021).","journal-title":"Drug Discov. Today"},{"key":"42784_CR13","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1021\/acschembio.9b00347","volume":"14","author":"KS Wong","year":"2019","unstructured":"Wong, K. S. & Houry, W. A. Chemical modulation of human mitochondrial ClpP: potential application in cancer therapeutics. ACS Chem. Biol. 14, 2349\u20132360 (2019).","journal-title":"ACS Chem. Biol."},{"key":"42784_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00306-1","volume":"10","author":"YG Lee","year":"2021","unstructured":"Lee, Y. G. et al. LONP1 and ClpP cooperatively regulate mitochondrial proteostasis for cancer cell survival. Oncogenesis 10, 18 (2021).","journal-title":"Oncogenesis"},{"key":"42784_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar, D. S. et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19, 649\u2013658 (2017).","journal-title":"Neoplasia"},{"key":"42784_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar, D. S. et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia 25, 18\u201327 (2022).","journal-title":"Neoplasia"},{"key":"42784_CR17","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41392-022-01200-x","volume":"7","author":"Z Niu","year":"2022","unstructured":"Niu, Z., Jin, R., Zhang, Y. & Li, H. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials. Signal Transduct Target Ther 7, 353 (2022).","journal-title":"Signal Transduct Target Ther"},{"key":"42784_CR18","doi-asserted-by":"publisher","first-page":"115232","DOI":"10.1016\/j.bcp.2022.115232","volume":"204","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. IMP075 targeting ClpP for colon cancer therapy in vivo and in vitro. Biochem. Pharmacol. 204, 115232 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"42784_CR19","doi-asserted-by":"publisher","first-page":"14602","DOI":"10.1002\/anie.201808189","volume":"57","author":"M Stahl","year":"2018","unstructured":"Stahl, M. et al. Selective activation of human caseinolytic protease P (ClpP). Angew. Chem. Int. Ed. Engl. 57, 14602\u201314607 (2018).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"42784_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34753-0","volume":"13","author":"B Wei","year":"2022","unstructured":"Wei, B. et al. Anti-infective therapy using species-specific activators of Staphylococcus aureus ClpP. Nat. Commun. 13, 6909 (2022).","journal-title":"Nat. Commun."},{"key":"42784_CR21","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/nm1306","volume":"11","author":"H Br\u00f6tz-Oesterhelt","year":"2005","unstructured":"Br\u00f6tz-Oesterhelt, H. et al. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat. Med. 11, 1082\u20131087 (2005).","journal-title":"Nat. Med."},{"key":"42784_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/10409238.2014.925421","volume":"49","author":"K Liu","year":"2014","unstructured":"Liu, K., Ologbenla, A. & Houry, W. A. Dynamics of the ClpP serine protease: a model for self-compartmentalized proteases. Crit. Rev. Biochem. Mol. Biol. 49, 400\u2013412 (2014).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"42784_CR23","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1021\/acs.jafc.1c01470","volume":"69","author":"T Yang","year":"2021","unstructured":"Yang, T. et al. Dysregulation of ClpP by small-molecule activators used against Xanthomonas oryzae pv. oryzae infections. J. Agric. Food Chem. 69, 7545\u20137553 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"42784_CR24","doi-asserted-by":"publisher","first-page":"19000","DOI":"10.1074\/jbc.M001222200","volume":"275","author":"M Liang","year":"2000","unstructured":"Liang, M. et al. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J. Biol. Chem. 275, 19000\u201319008 (2000).","journal-title":"J. Biol. Chem."},{"key":"42784_CR25","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/nprot.2007.321","volume":"2","author":"FH Niesen","year":"2007","unstructured":"Niesen, F. H., Berglund, H. & Vedadi, M. The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat. Protoc. 2, 2212\u20132221 (2007).","journal-title":"Nat. Protoc."},{"key":"42784_CR26","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1021\/acschembio.6b00390","volume":"11","author":"T Ni","year":"2016","unstructured":"Ni, T. et al. Characterization of gain-of-function mutant provides new insights into ClpP structure. ACS Chem. Biol. 11, 1964\u20131972 (2016).","journal-title":"ACS Chem. Biol."},{"key":"42784_CR27","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1073\/pnas.1018854108","volume":"109","author":"LM Heiser","year":"2012","unstructured":"Heiser, L. M. et al. Subtype and pathway specific responses to anticancer compounds in breast cancer. Proc. Natl. Acad. Sci. USA. 109, 2724\u20132729 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"42784_CR28","first-page":"3","volume":"44","author":"RZ Zhao","year":"2019","unstructured":"Zhao, R. Z., Jiang, S., Zhang, L. & Yu, Z. B. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int. J. Mol. Med. 44, 3\u201315 (2019).","journal-title":"Int. J. Mol. Med."},{"key":"42784_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84\u201387 (2013).","journal-title":"Science"},{"key":"42784_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.tibs.2004.06.006","volume":"29","author":"AP Bracken","year":"2004","unstructured":"Bracken, A. P., Ciro, M., Cocito, A. & Helin, K. E2F target genes: unraveling the biology. Trends Biochem. Sci. 29, 409\u2013417 (2004).","journal-title":"Trends Biochem. Sci."},{"key":"42784_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrm3567","volume":"14","author":"FA Dick","year":"2013","unstructured":"Dick, F. A. & Rubin, S. M. Molecular mechanisms underlying RB protein function. Nat. Rev. Mol. Cell Biol. 14, 297\u2013306 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"42784_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0092-8674(00)00010-6","volume":"102","author":"R Agami","year":"2000","unstructured":"Agami, R. & Bernards, R. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102, 55\u201366 (2000).","journal-title":"Cell"},{"key":"42784_CR33","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/leu.2010.6","volume":"24","author":"LJ Mah","year":"2010","unstructured":"Mah, L. J., El-Osta, A. & Karagiannis, T. C. \u03b3H2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 24, 679\u2013686 (2010).","journal-title":"Leukemia"},{"key":"42784_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nprot.2006.5","volume":"1","author":"PL Olive","year":"2006","unstructured":"Olive, P. L. & Ban\u00e1th, J. P. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 1, 23\u201329 (2006).","journal-title":"Nat. Protoc."},{"key":"42784_CR35","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41580-021-00394-2","volume":"22","author":"JH Lee","year":"2021","unstructured":"Lee, J. H. & Paull, T. T. Cellular functions of the protein kinase ATM and their relevance to human disease. Nat. Rev. Mol. Cell Biol. 22, 796\u2013814 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"42784_CR36","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1140321","volume":"316","author":"S Matsuoka","year":"2007","unstructured":"Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160\u20131166 (2007).","journal-title":"Science"},{"key":"42784_CR37","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1017\/erm.2020.3","volume":"22","author":"HL Smith","year":"2020","unstructured":"Smith, H. L., Southgate, H., Tweddle, D. A. & Curtin, N. J. DNA damage checkpoint kinases in cancer. Expert Rev. Mol. Med. 22, e2 (2020).","journal-title":"Expert Rev. Mol. Med."},{"key":"42784_CR38","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071\u20131078 (2009).","journal-title":"Nature"},{"key":"42784_CR39","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","volume":"64","author":"I Hickson","year":"2004","unstructured":"Hickson, I. et al. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64, 9152\u20139159 (2004).","journal-title":"Cancer Res."},{"key":"42784_CR40","doi-asserted-by":"publisher","first-page":"eaat1719","DOI":"10.1126\/sciadv.aat1719","volume":"4","author":"ST Durant","year":"2018","unstructured":"Durant, S. T. et al. The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models. Sci. Adv. 4, eaat1719 (2018).","journal-title":"Sci. Adv."},{"key":"42784_CR41","doi-asserted-by":"publisher","first-page":"171ra117","DOI":"10.1126\/scitranslmed.3004828","volume":"5","author":"JE Allen","year":"2013","unstructured":"Allen, J. E. et al. Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects. Sci. Transl. Med. 5, 171ra117 (2013).","journal-title":"Sci. Transl. Med."},{"key":"42784_CR42","doi-asserted-by":"publisher","first-page":"ra18","DOI":"10.1126\/scisignal.aac4374","volume":"9","author":"CL Kline","year":"2016","unstructured":"Kline, C. L. et al. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2\u03b1 kinases. Sci. Signal. 9, ra18 (2016).","journal-title":"Sci. Signal."},{"key":"42784_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jgg.2020.12.004","volume":"48","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Xue, Y., Jin, Y. & Ji, H. Lung stem cells in regeneration and tumorigenesis. J. Genet. Genom. 48, 268\u2013276 (2021).","journal-title":"J. Genet. Genom."},{"key":"42784_CR44","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.celrep.2019.07.027","volume":"28","author":"M-H Hsieh","year":"2019","unstructured":"Hsieh, M.-H. et al. p63 and SOX2 dictate glucose reliance and metabolic vulnerabilities in squamous cell carcinomas. Cell Rep. 28, 1860\u20131878.e1869 (2019).","journal-title":"Cell Rep."},{"key":"42784_CR45","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-023-05793-3","volume":"615","author":"M Han","year":"2023","unstructured":"Han, M. et al. Spatial mapping of mitochondrial networks and bioenergetics in lung cancer. Nature 615, 712\u2013719 (2023).","journal-title":"Nature"},{"key":"42784_CR46","doi-asserted-by":"publisher","first-page":"E3978","DOI":"10.1073\/pnas.1716589115","volume":"115","author":"Q Wu","year":"2018","unstructured":"Wu, Q. et al. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis. Proc. Natl. Acad. Sci. USA. 115, E3978\u2013E3986 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"42784_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan, K., Werner, M. & Chandel, N. S. Mitochondrial metabolism as a target for cancer therapy. Cell Metab. 32, 341\u2013352 (2020).","journal-title":"Cell Metab."},{"key":"42784_CR48","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","volume":"162","author":"K Birsoy","year":"2015","unstructured":"Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540\u2013551 (2015).","journal-title":"Cell"},{"key":"42784_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap, T. A. et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat. Med. 29, 115\u2013126 (2023).","journal-title":"Nat. Med."},{"key":"42784_CR50","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neo.2020.09.005","volume":"22","author":"VV Prabhu","year":"2020","unstructured":"Prabhu, V. V. et al. ONC201 and imipridones: anti-cancer compounds with clinical efficacy. Neoplasia 22, 725\u2013744 (2020).","journal-title":"Neoplasia"},{"key":"42784_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.str.2023.01.002","volume":"31","author":"LL Zhou","year":"2023","unstructured":"Zhou, L. L. & Yang, C. G. Structural insights into the evolutionary simplification of human ClpP activators. Structure 31, 125\u2013127 (2023).","journal-title":"Structure"},{"key":"42784_CR52","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1107\/S1600576719001183","volume":"52","author":"F Yu","year":"2019","unstructured":"Yu, F. et al. Aquarium: an automatic data-processing and experiment information management system for biological macromolecular crystallography beamlines. J. Appl. Crystallogr. 52, 472\u2013477 (2019).","journal-title":"J. Appl. Crystallogr."},{"key":"42784_CR53","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"42784_CR54","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jsb.2004.07.004","volume":"148","author":"SG Kang","year":"2004","unstructured":"Kang, S. G., Maurizi, M. R., Thompson, M., Mueser, T. & Ahvazi, B. Crystallography and mutagenesis point to an essential role for the N-terminus of human mitochondrial ClpP. J. Struct. Biol. 148, 338\u2013352 (2004).","journal-title":"J. Struct. Biol."},{"key":"42784_CR55","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","volume":"53","author":"GN Murshudov","year":"1997","unstructured":"Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53, 240\u2013255 (1997).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"42784_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"42784_CR57","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"42784_CR58","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/cjoc.202000462","volume":"39","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. A peptide binder of E3 ligase adaptor SPOP disrupts oncogenic SPOP-protein interactions in kidney cancer cells. Chin. J. Chem. 39, 274\u2013280 (2021).","journal-title":"Chin. J. Chem."},{"key":"42784_CR59","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1093\/jnci\/djn213","volume":"100","author":"J Xing","year":"2008","unstructured":"Xing, J. et al. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J. Natl. Cancer Inst. 100, 1104\u20131112 (2008).","journal-title":"J. Natl. Cancer Inst."},{"key":"42784_CR60","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"},{"key":"42784_CR61","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295 (2015).","journal-title":"Nat. Biotechnol."},{"key":"42784_CR62","doi-asserted-by":"publisher","first-page":"nwab014","DOI":"10.1093\/nsr\/nwab014","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Targeting HSPA1A in ARID2-deficient lung adenocarcinoma. Natl Sci. Rev. 8, nwab014 (2021).","journal-title":"Natl Sci. Rev."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42784-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42784-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42784-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T19:02:11Z","timestamp":1699038131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42784-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42784"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-42784-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.-L.Z., T.Z. and C.-G.Y. are named inventors of pending patent application (2023106791890, to the Chinese Patent Office) related to the work described. Patent applicant is Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The structures of ZK11 and ZK53 are covered in the patent application. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7069"}}